Patient‐Centered Teledermatology: Bridging Pharmacies and Dermatologists
International Journal of Telemedicine and Applications · 2026-01 · 2026 (1)
DOI: 10.1155/ijta/9409013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Telemedicine and Applications, online erschienen am 29.07.2026. Verfasst von Nuria Perez-Cullell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Direction Médicale et Relation Patient/Consommateur, Pierre Fabre Laboratories, Toulouse, France. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Les Laboratories Pierre Fabre.
Abstract (Originalsprache)
Background
The chronic shortage of dermatologists in France results in average waiting times of 3 months, compromising equitable access to care and early diagnosis of severe conditions such as skin cancers. This pilot project evaluates the feasibility, effectiveness, and acceptability of a tele‐expertise platform connecting community pharmacists and dermatologists.
Methods
From March 2024 to March 2025, 40 pharmacies (18 urban and 22 rural) submitted 731 dermatological cases via a secure platform, following pharmacist training in clinical photography and best practices. Twelve volunteer dermatologists responded within a target of 24–48 h. Data focused on utilization, response times, pathologies, satisfaction (pharmacist surveys and pharmacist‐reported patient feedback), and qualitative feedback from an expert board.
Results
Seven hundred fourteen tele‐expertises were completed, with a mean response time of 5.4 days, reflecting early implementation constraints and progressively improving over time (reduced to 1–2 days by study end; 83% < 48 h in February 2025). The main conditions include suspected melanoma (7), carcinomas (27), actinic keratosis, eczema, atopic dermatitis, rosacea, vitiligo, and shingles. Pharmacist satisfaction reached 72% (NPS 24%; 94% recommending a scale‐up with adaptations). Pharmacists reported that 88% of patients were satisfied. Limitations comprised the lack of e‐prescriptions and the nonintegration of primary care physicians.
Conclusion
This pharmacy‐centered model improves rapid access to dermatological expertise, reduces diagnostic delays, and satisfies users, but requires integration into coordinated care pathways (with primary care physicians), pharmacist remuneration, and legal/financial reforms for sustainability. A second pilot is testing these recommendations.
Autor:innen und Institutionen
- Direction Médicale et Relation Patient/Consommateur, Pierre Fabre Laboratories, Toulouse, France.
- Private Practice, Lherm, France.
- Department of Dermatology, Centre Hospitalier Marie-Josée Treffot, Hyères, France.
- Pharmacie de l'Europe, Maurs, France.
ORCID-Profile: Nuria Perez-Cullell, Valérie Buresi
Förderung
- Les Laboratories Pierre Fabre
Zitieren
APA
Perez-Cullell, N., Buresi, V., Homehr, N., Brutin, J. L., & Fraysse, J. (2026). Patient‐Centered Teledermatology: Bridging Pharmacies and Dermatologists. International Journal of Telemedicine and Applications, 2026(1). https://doi.org/10.1155/ijta/9409013
Vancouver
Perez-Cullell N, Buresi V, Homehr N, Brutin JL, Fraysse J. Patient‐Centered Teledermatology: Bridging Pharmacies and Dermatologists. International Journal of Telemedicine and Applications. 2026;2026(1). doi:10.1155/ijta/9409013
BibTeX
@article{PerezCullell2026,
author = {Perez-Cullell, Nuria and Buresi, Valérie and Homehr, Nicolas and Brutin, Jean-Ludovic and Fraysse, Julie},
title = {Patient‐Centered Teledermatology: Bridging Pharmacies and Dermatologists},
journal = {International Journal of Telemedicine and Applications},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijta/9409013}
}
EUVIMED